Biomarker Analysis

OTHER20 trials

Sponsors

Royal Marsden NHS Foundation Trust, Cancer Trials Ireland, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Ohio State University Comprehensive Cancer Center, Duke University

Conditions

Advanced Colorectal CancerAdvanced Urothelial CarcinomaAtypical Ductal Breast HyperplasiaBRCA1 Gene MutationBRCA2 Gene MutationBone Metastatic Castration-Resistant Prostate CancerBreast CancerBreast Carcinoma

Early Phase 1

Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer

CompletedNCT02204943

Duke UniversityBone Metastatic Castration-Resistant Prostate Cancer

Start: 2015-05-06End: 2017-07-31Updated: 2018-06-08

Phase 1

Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30

CompletedNCT00753207

Cancer Trials IrelandBreast Cancer

Start: 2007-10-31End: 2012-03-31Updated: 2016-02-15

Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer

TerminatedNCT02457910

Vanderbilt-Ingram Cancer CenterEstrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative +4

Start: 2015-06-30End: 2022-08-08Updated: 2022-08-22

Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

SuspendedNCT07025538

City of Hope Medical CenterHematopoietic and Lymphatic System Neoplasm

Start: 2026-03-09End: 2029-06-22Target: 42Updated: 2026-02-23

Unknown Phase

Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer

Royal Marsden NHS Foundation TrustTesticular Germ Cell Tumor

Start: 2006-04-30Target: 300Updated: 2013-08-26

Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer

CompletedNCT00897338

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsBreast Cancer

Start: 2007-08-31End: 2014-01-31Updated: 2015-10-12

ANGIOPREDICT. ICORG 12-16, V3

CompletedNCT01822444

Cancer Trials IrelandAdvanced Colorectal Cancer

Start: 2012-11-30End: 2017-02-28Updated: 2023-04-06

Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

CompletedNCT01840306

Cancer Trials IrelandBreast Cancer, HER2 Negative Breast Cancer, HER2 Positive Breast Cancer

Start: 2012-10-12End: 2023-05-24Target: 330Updated: 2025-07-08

Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer

CompletedNCT01975363

Ohio State University Comprehensive Cancer CenterAtypical Ductal Breast Hyperplasia, BRCA1 Gene Mutation, BRCA2 Gene Mutation +2

Start: 2013-06-30End: 2016-09-19Updated: 2019-08-30

High Definition Single Cell Analysis in Colorectal Cancer

CompletedNCT02809716

University of Southern CaliforniaMetastatic Carcinoma in the Liver, Stage IV Colorectal Cancer

Start: 2016-08-01End: 2020-05-29Updated: 2023-08-14

Throat and Other HPV-Related Cancers in Men: Identifying Them Early

Active, not recruitingNCT02897427

Baylor College of MedicineHuman Papillomavirus Infection

Start: 2017-03-28End: 2027-03-28Target: 1500Updated: 2026-01-26

Acute Exercise Intervention in Breast Cancer Survivors

TerminatedNCT03779867

Fred Hutchinson Cancer CenterBreast Carcinoma

Start: 2019-03-25End: 2024-12-31Updated: 2025-01-23

Immunologic Biomarker Profile of Cerebrospinal Fluid

CompletedNCT04202055

Centre Hospitalier Universitaire de NīmesMultiple Sclerosis, Neuromyelitis Optica

Start: 2018-01-02End: 2019-08-31Updated: 2019-12-17

A Study of miRNA 371 in Patients With Germ Cell Tumors

Active, not recruitingNCT04435756

SWOG Cancer Research NetworkGerm Cell Tumor, Metachronous Malignant Neoplasm, Seminoma +4

Start: 2020-07-28End: 2028-01-01Target: 956Updated: 2026-03-12

Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty

RecruitingNCT04717869

University of California, Los AngelesFrailty, Sarcopenia

Start: 2023-09-22End: 2026-07-01Target: 250Updated: 2026-01-30

MicroRNA as Markers in Testicular Cancer

RecruitingNCT04914026

Haukeland University HospitalNon-Seminoma Testicular Cancer, Relapse Testicular Cancer, Seminoma +5

Start: 2016-12-31End: 2026-12-31Target: 350Updated: 2022-08-08

Diagnostic Reliability of OCT Biomarkers for iERM

CompletedNCT04997876

Vienna Institute for Research in Ocular SurgeryIdiopathic Epiretinal Membranes

Start: 2021-01-11End: 2021-08-21Updated: 2021-08-24

A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis

RecruitingNCT06875336

University of CologneExtrapulmonary Tuberculosis

Start: 2023-03-06End: 2025-12-31Target: 150Updated: 2025-03-13

A Biomarker Study to Predict Treatment Outcomes of Enfortumab Vedotin in Advanced Urothelial Carcinoma

Active, not recruitingNCT07063758

National Taiwan University Clinical Trial CenterAdvanced Urothelial Carcinoma

Start: 2025-04-01End: 2029-12-31Target: 200Updated: 2025-07-16

Pharmacogenomic and Circulating Biomarkers for CDK4/6 Inhibitors

Enrolling by invitationNCT07100054

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sBreast Cancer, CDK4/6 Inhibitor, CYP3A4 Protein, Human +2

Start: 2025-10-10End: 2028-09-30Target: 100Updated: 2025-12-12

Related Papers

Effects of acute exercise on inflammatory and metabolic biomarkers in women: a randomized controlled trial.

2025-11-07

Analysis of cell free DNA to predict outcome to bevacizumab therapy in colorectal cancer patients

npj Genomic Medicine2024-05-292 citations

North American patterns of care in clinical stage I testicular cancer from SWOG S1823.

Journal of Clinical Oncology2024-01-29

Plasma miR371 as Reliable Biomarker for Testicular Cancer Surveillance

Oncology Times2023-09-05

Abstract 5584: Analysis of cell free DNA to predict outcome to Bevacizumab combination therapy in metastatic colorectal cancer patients

Cancer Research2023-04-04

Circulating Tumor Cell Genomic Evolution and Hormone Therapy Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer

Molecular Cancer Research2021-03-2625 citations

Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.

2019-05-2811 citations

Analysis of genomic alterations in matched circulating tumor cell DNA (CTC DNA) and plasma tumor DNA (ctDNA) in men with metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology2018-05-20

Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.

Journal of Clinical Oncology2018-05-20

Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.

Journal of Clinical Oncology2018-02-201 citations

Androgen receptor‐positive, triple‐negative breast cancer

Cancer2017-04-1216 citations